LNCARGI and fatty liver disease: However, this mechanism unlikely accounts for the beneficial effect of Arg-II deficiency in obesity-induced liver steatosis in our study, since Arg-II is not expressed in hepatocytes and no change in Arg-I level or total arginase activity in liver of Arg-II−/− mice was observed.